Dalen Johnson
Nurse Practitioner · East Carbon, UTNPI 1922318450
Payments from drug & device makers
Across 104 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$795
- AstraZeneca$202
- Lilly USA, LLC$177
- Mylan Specialty L.p.$110
- Pfizer$85
- Myriad Women's Health, Inc.$71
- plus $441 from 15 others
What the payments were for
- Food & beverage$1,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $795 |
| AstraZeneca | 12 | $202 |
| Lilly USA, LLC | 10 | $177 |
| Mylan Specialty L.p. | 6 | $110 |
| Pfizer | 5 | $85 |
| Myriad Women's Health, Inc. | 1 | $71 |
| Boehringer Ingelheim | 4 | $71 |
| Novo Nordisk | 4 | $66 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Amgen | 2 | $36 |
| Abbott | 1 | $22 |
| Exact Sciences | 1 | $21 |
| Organon | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
How this compares
$1,881 in reported general payments places this provider in the 85th percentile of 979 nurse practitioner providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 104 | $103,342 |
| JardianceEmpagliflozin | 100 | $85,074 |
| MounjaroTirzepatide | 73 | $83,774 |
| EliquisApixaban | 83 | $45,735 |
| Invega SustennaPaliperidone Palmitate | 17 | $40,160 |
| XareltoRivaroxaban | 37 | $27,561 |
| TrulicityDulaglutide | 26 | $26,308 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $24,846 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $24,092 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $20,881 |
| UbrelvyUbrogepant | 18 | $18,205 |
| FarxigaDapagliflozin Propanediol | 22 | $16,525 |
| QuliptaAtogepant | 12 | $12,898 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $11,780 |
| LinzessLinaclotide | 11 | $9,997 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $177 | $110,08199 claims |
| Novo NordiskOzempic | $66 | $103,342104 claims |
| Boehringer IngelheimJardiance, Tradjenta | $71 | $90,702111 claims |
| PfizerEliquis, Premarin | $85 | $48,41196 claims |
| AbbVieUbrelvy, Qulipta, Linzess | $795 | $41,10041 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $202 | $28,30541 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in East Carbon
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Geoffrey OsmondDraper$62K
- Trenton GraySouth Salt Lake$40K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Phillip BowmanSalt Lake City$18K
- Lynn LarsenOgden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.